Notes / Company

Gennex Laboratories Ltd.

GENNEX BSE 531739 ISIN INE509C01026 Pharmaceuticals

Fundamentals

Market cap: ₹260 cr
P/E: 12.41×
ROE: 9.71%
Debt / equity: 0.13
52-week range: 7.05 — 17.25

Research on Tijori Finance

Company snapshot

Gennex Laboratories Ltd.

Pharmaceuticals

₹260 cr

P/E 12.41×

Latest quarter · Mar 2026

Sales₹61 cr

Net profit₹4 cr

Op. margin+9.7%

EPS₹0.18

Strength & growth

Debt / equity0.13×

Current ratio4.07×

Sales CAGR+16.3%

EPS CAGR+3.0%

The timeline — 1 note on Gennex Laboratories Ltd.

June 2026

10 Jun 26 · 4:29 PM IST Lead

Lead · Credit · Micro cap

Gennex promoter's pledge ratio jumps to 24% on a small loan

A ₹1.25 crore loan pushed Premier Fiscal's pledged stock to 12.5 million shares. The company's market cap is just ₹256 crore.

Verify on exchange BSE filings for GENNEX NSE filings for GENNEX Tijori Finance company page